Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice

F. Fornai, M. G. Alessandri, F. Fascetti, F. Vaglini, G. U. Corsini

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Recent findings have shown that excitatory amino acid may be involved in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. At the same time, evidence is accumulating that the endogenous noradrenergic system plays a protective role in MPTP-induced striatal dopamine (DA) depletion and nigral dopaminergic cell death. Recently, α2-adrenoceptors located on glutamatergic axons have been shown to inhibit glutamate overflow. In this study, we evaluated the effects of an α2-agonist (clonidine) and an α2- antagonist (yohimbine) on MPTP-induced striatal DA depletion and tyrosine hydroxylase activity reduction. We show that clonidine is able to prevent the neurotoxicity of MPTP in mice. To exert this effect, clonidine (0.5 mg/kg) must be administered at least twice (30 min before and 30 min after MPTP). Administration of another α2-agonist (detomidine, 0.3 mg/kg) attenuated the neurotoxicity induced by MPTP. We provide evidence that the protective effect obtained with clonidine was not due to decreased striatal content of 1- methyl-4-phenylpyridinium (MPP+). We also show that yohimbine, which is a classic α2-adrenoceptor antagonist with low affinity for imidazoline receptors, produced by itself an enhancement of MPTP toxicity and was able to block the protective effect of clonidine. These data raise the possibility that α2-adrenoceptor may modulate the susceptibility of the nigrostriatal dopaminergic pathway to neurotoxicity.

Original languageEnglish
Pages (from-to)704-709
Number of pages6
JournalJournal of Neurochemistry
Volume65
Issue number2
Publication statusPublished - 1995

Fingerprint

Corpus Striatum
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Tyrosine 3-Monooxygenase
Clonidine
Dopamine
Adrenergic Receptors
Yohimbine
Toxicity
Imidazoline Receptors
1-Methyl-4-phenylpyridinium
Excitatory Amino Acids
Substantia Nigra
Cell death
Axons
Glutamic Acid
Cell Death

Keywords

  • 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine
  • Clonidine
  • Detomidine
  • Parkinsonism
  • Yohimbine

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice. / Fornai, F.; Alessandri, M. G.; Fascetti, F.; Vaglini, F.; Corsini, G. U.

In: Journal of Neurochemistry, Vol. 65, No. 2, 1995, p. 704-709.

Research output: Contribution to journalArticle

@article{5ff277b6b4b843f785a3f38edd9632f2,
title = "Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice",
abstract = "Recent findings have shown that excitatory amino acid may be involved in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. At the same time, evidence is accumulating that the endogenous noradrenergic system plays a protective role in MPTP-induced striatal dopamine (DA) depletion and nigral dopaminergic cell death. Recently, α2-adrenoceptors located on glutamatergic axons have been shown to inhibit glutamate overflow. In this study, we evaluated the effects of an α2-agonist (clonidine) and an α2- antagonist (yohimbine) on MPTP-induced striatal DA depletion and tyrosine hydroxylase activity reduction. We show that clonidine is able to prevent the neurotoxicity of MPTP in mice. To exert this effect, clonidine (0.5 mg/kg) must be administered at least twice (30 min before and 30 min after MPTP). Administration of another α2-agonist (detomidine, 0.3 mg/kg) attenuated the neurotoxicity induced by MPTP. We provide evidence that the protective effect obtained with clonidine was not due to decreased striatal content of 1- methyl-4-phenylpyridinium (MPP+). We also show that yohimbine, which is a classic α2-adrenoceptor antagonist with low affinity for imidazoline receptors, produced by itself an enhancement of MPTP toxicity and was able to block the protective effect of clonidine. These data raise the possibility that α2-adrenoceptor may modulate the susceptibility of the nigrostriatal dopaminergic pathway to neurotoxicity.",
keywords = "1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine, Clonidine, Detomidine, Parkinsonism, Yohimbine",
author = "F. Fornai and Alessandri, {M. G.} and F. Fascetti and F. Vaglini and Corsini, {G. U.}",
year = "1995",
language = "English",
volume = "65",
pages = "704--709",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice

AU - Fornai, F.

AU - Alessandri, M. G.

AU - Fascetti, F.

AU - Vaglini, F.

AU - Corsini, G. U.

PY - 1995

Y1 - 1995

N2 - Recent findings have shown that excitatory amino acid may be involved in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. At the same time, evidence is accumulating that the endogenous noradrenergic system plays a protective role in MPTP-induced striatal dopamine (DA) depletion and nigral dopaminergic cell death. Recently, α2-adrenoceptors located on glutamatergic axons have been shown to inhibit glutamate overflow. In this study, we evaluated the effects of an α2-agonist (clonidine) and an α2- antagonist (yohimbine) on MPTP-induced striatal DA depletion and tyrosine hydroxylase activity reduction. We show that clonidine is able to prevent the neurotoxicity of MPTP in mice. To exert this effect, clonidine (0.5 mg/kg) must be administered at least twice (30 min before and 30 min after MPTP). Administration of another α2-agonist (detomidine, 0.3 mg/kg) attenuated the neurotoxicity induced by MPTP. We provide evidence that the protective effect obtained with clonidine was not due to decreased striatal content of 1- methyl-4-phenylpyridinium (MPP+). We also show that yohimbine, which is a classic α2-adrenoceptor antagonist with low affinity for imidazoline receptors, produced by itself an enhancement of MPTP toxicity and was able to block the protective effect of clonidine. These data raise the possibility that α2-adrenoceptor may modulate the susceptibility of the nigrostriatal dopaminergic pathway to neurotoxicity.

AB - Recent findings have shown that excitatory amino acid may be involved in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. At the same time, evidence is accumulating that the endogenous noradrenergic system plays a protective role in MPTP-induced striatal dopamine (DA) depletion and nigral dopaminergic cell death. Recently, α2-adrenoceptors located on glutamatergic axons have been shown to inhibit glutamate overflow. In this study, we evaluated the effects of an α2-agonist (clonidine) and an α2- antagonist (yohimbine) on MPTP-induced striatal DA depletion and tyrosine hydroxylase activity reduction. We show that clonidine is able to prevent the neurotoxicity of MPTP in mice. To exert this effect, clonidine (0.5 mg/kg) must be administered at least twice (30 min before and 30 min after MPTP). Administration of another α2-agonist (detomidine, 0.3 mg/kg) attenuated the neurotoxicity induced by MPTP. We provide evidence that the protective effect obtained with clonidine was not due to decreased striatal content of 1- methyl-4-phenylpyridinium (MPP+). We also show that yohimbine, which is a classic α2-adrenoceptor antagonist with low affinity for imidazoline receptors, produced by itself an enhancement of MPTP toxicity and was able to block the protective effect of clonidine. These data raise the possibility that α2-adrenoceptor may modulate the susceptibility of the nigrostriatal dopaminergic pathway to neurotoxicity.

KW - 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine

KW - Clonidine

KW - Detomidine

KW - Parkinsonism

KW - Yohimbine

UR - http://www.scopus.com/inward/record.url?scp=0029111461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029111461&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 704

EP - 709

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -